Shiga Toxin–Producing Escherichia coli Transmission via Fecal Microbiota Transplant

Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)

McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1085 · Cited by 2,690 · see citing works

Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections

Surawicz, C. M., Brandt, L. J., Binion, D. G., Ananthakrishnan, A. N., Curry, S. R., Gilligan, P. H., McFarland, L. V., Mellow, M., & Zuckerbraun, B. S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.4 · Cited by 1,645 · see citing works

Drug-Resistant <i>E. coli</i> Bacteremia Transmitted by Fecal Microbiota Transplant

DeFilipp, Z., Bloom, P. P., Torres Soto, M., Mansour, M. K., Sater, M. R. A., Huntley, M. H., Turbett, S., Chung, R. T., Chen, Y.-B., & Hohmann, E. L. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1910437 · Cited by 1,281 · see citing works

Systematic review with meta‐analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory <i>Clostridium difficile</i> infection

Quraishi, M. N., Widlak, M., Bhala, N., Moore, D., Price, M., Sharma, N., & Iqbal, T. H. (2017) · Alimentary Pharmacology &amp; Therapeutics · doi:10.1111/apt.14201 · Cited by 617 · see citing works

International consensus conference on stool banking for faecal microbiota transplantation in clinical practice

Cammarota, G., Ianiro, G., Kelly, C. R., Mullish, B. H., Allegretti, J. R., Kassam, Z., Putignani, L., Fischer, M., Keller, J. J., Costello, S. P., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-319548 · Cited by 506 · see citing works

The use of faecal microbiota transplant as treatment for recurrent or refractoryClostridium difficileinfection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

Mullish, B. H., Quraishi, M. N., Segal, J. P., McCune, V. L., Baxter, M., Marsden, G. L., Moore, D., Colville, A., Bhala, N. B., Iqbal, T. H., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-316818 · Cited by 338 · see citing works

Recommendations for diagnosis of shiga toxin--producing Escherichia coli infections by clinical laboratories.

Gould, L. H., Bopp, C. A., Strockbine, N., Atkinson, R., Baselski, V. S., Body, B. A., Carey, R., Crandall, C. M., Hurd, S., Kaplan, R., et al. (2009) · PubMed · Cited by 304 · see citing works

Faecal microbiota transplantation for Clostridium difficile ‐associated diarrhoea: a systematic review of randomised controlled trials

Moayyedi, P., Yuan, Y., Baharith, H., & Ford, A. C. (2017) · The Medical Journal of Australia · doi:10.5694/mja17.00295 · Cited by 127 · see citing works

Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children

Davidovics, Z. H., Michail, S. K., Nicholson, M. R., Kociolek, L. K., Pai, N., Hansen, R., Schwerd, T., Maspons, A., Shamir, R., Szajewska, H., et al. (2018) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002205 · Cited by 127 · see citing works

Donor Screening for Fecal Microbiota Transplantation

Kassam, Z., Dubois, N. E., Ramakrishna, B., Ling, K., Qazi, T., Smith, M. B., Kelly, C. R., Fischer, M., Allegretti, J. R., Budree, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1913670 · Cited by 127 · see citing works

Whole-Genome-Based Public Health Surveillance of Less Common Shiga Toxin-Producing Escherichia coli Serovars and Untypeable Strains Identifies Four Novel O Genotypes

Lang, C., Hiller, M., Konrad, R., Fruth, A., & Flieger, A. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.00768-19 · Cited by 29 · see citing works

Diagnostic Test Accuracy of Commercial Tests for Detection of Shiga Toxin-Producing Escherichia coli: A Systematic Review and Meta-Analysis.

Tarr, G., Lin, C.-Y., Vandermeer, B., Lorenzetti, D., Tarr, P., Chui, L., Hartling, L., & Freedman, S. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvz006 · Cited by 5 · see citing works

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases

Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193 · see citing works

European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults

van Prehn, J., Reigadas, E., Vogelzang, E. H., Bouza, E., Hristea, A., Guery, B., Krutova, M., Norén, T., Allerberger, F., Coia, J. E., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.09.038 · Cited by 640 · see citing works

Antibiotic perturbations to the gut microbiome

Fishbein, S. R. S., Mahmud, B., & Dantas, G. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00933-y · Cited by 440 · see citing works

Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases

Ianiro, G., Punčochář, M., Karcher, N., Porcari, S., Armanini, F., Asnicar, F., Beghini, F., Blanco-Míguez, A., Cumbo, F., Manghi, P., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01964-3 · Cited by 366 · see citing works

VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection

Louie, T., Golan, Y., Khanna, S., Bobilev, D., Erpelding, N., Fratazzi, C., Carini, M., Menon, R., Ruisi, M., Norman, J. M., et al. (2023) · JAMA · doi:10.1001/jama.2023.4314 · Cited by 209 · see citing works

Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement

Woodworth, M. H., Conrad, R. E., Haldopoulos, M. E., Pouch, S. M., Babiker, A., Mehta, A. K., Sitchenko, K. L., Wang, C. H., Strudwick, A. F., Ingersoll, J., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abo2750 · Cited by 114 · see citing works

Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy

Zhang, Y., Xiao, Z., Yu, X., Novák, P., Gui, Q., & Yin, K. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1120168 · Cited by 110 · see citing works

Long-term Safety of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection

Saha, S., Mara, K. C., Pardi, D. S., & Khanna, S. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.01.010 · Cited by 103 · see citing works

Microbiome therapeutics for hepatic encephalopathy

Bloom, P. P., Tapper, E. B., Young, V. B., & Lok, A. S.-F. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.08.004 · Cited by 95 · see citing works

The Metabolic Role and Therapeutic Potential of the Microbiome

Olofsson, L. E., & Bäckhed, F. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac004 · Cited by 95 · see citing works

Therapeutic Targeting of the Respiratory Microbiome

Chotirmall, S. H., Bogaert, D., Chalmers, J. D., Cox, M. J., Hansbro, P. M., Huang, Y. J., Molyneaux, P. L., O’Dwyer, D. N., Pragman, A. A., Rogers, G. B., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202112-2704pp · Cited by 88 · see citing works

The functions of gut microbiota-mediated bile acid metabolism in intestinal immunity

He, Y., Shaoyong, W., Chen, Y., Li, M., Gan, Y., Sun, L., Liu, Y., Wang, Y., & Jin, M. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.05.015 · Cited by 95 · see citing works

Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial

Orenstein, R., Dubberke, E. R., Khanna, S., Lee, C., Yoho, D. S., Johnson, S., Hecht, G. A., DuPont, H. L., Gerding, D. N., Blount, K., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07256-y · Cited by 83 · see citing works

The effect of a microbial ecosystem therapeutic (MET-2) on recurrent Clostridioides difficile infection: a phase 1, open-label, single-group trial

Kao, D., Wong, K., Franz, R., Cochrane, K., Sherriff, K., Chui, L., Lloyd, C., Roach, B., Bai, A. D., Petrof, E. O., et al. (2021) · The Lancet Gastroenterology &amp; Hepatology · doi:10.1016/s2468-1253(21)00007-8 · Cited by 81 · see citing works

Fecal Microbiota Transplantation: The Evolving Risk Landscape

Gupta, S., Mullish, B. H., & Allegretti, J. R. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001075 · Cited by 76 · see citing works

The role of the gut microbiome in colonization resistance and recurrent Clostridioides difficile infection

Seekatz, A. M., Safdar, N., & Khanna, S. (2022) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848221134396 · Cited by 79 · see citing works

Fecal microbiota transplantation: no longer cinderella in tumour immunotherapy

Yang, Y., An, Y., Dong, Y., Chu, Q., Wei, J., Wang, B., & Cao, H. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.104967 · Cited by 79 · see citing works

Gut microbiota as a new target for anticancer therapy: from mechanism to means of regulation

Sun, J., Song, S., Liu, J., Chen, F., Li, X., & Wu, G. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00678-x · Cited by 72 · see citing works

The Link between Gut Microbiota and Hepatic Encephalopathy

Won, S., Oh, K., Gupta, H., Ganesan, R., Sharma, S. P., Jeong, J., Yoon, S. J., Jeong, M. K., Min, B. H., Hyun, J. Y., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168999 · Cited by 69 · see citing works

Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease

Odenwald, M. A., Lin, H., Lehmann, C. J., Dylla, N. P., Cole, C. G., Mostad, J. D., Pappas, T. E., Ramaswamy, R., Moran, A., Hutchison, A. L., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01493-w · Cited by 68 · see citing works

Type 2 diabetes, gut microbiome, and systems biology: A novel perspective for a new era

Martínez-López, Y. E., Esquivel-Hernandez, D. A., Sánchez-Castañeda, J. P., Neri-Rosario, D., Guardado‐Mendoza, R., & Reséndis-Antonio, O. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2111952 · Cited by 56 · see citing works

Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases

Rodrigues, S. G., der Merwe, V., Krag, A. A., & Wiest, R. (2024) · Seminars in Immunology · doi:10.1016/j.smim.2023.101859 · Cited by 51 · see citing works

Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy via the gut-liver-brain axis

Luo, M., Xin, R., Hu, F.-R., Li, Y., Hu, S., & Bai, F. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i1.144 · Cited by 49 · see citing works

The potential utility of fecal (or intestinal) microbiota transplantation in controlling infectious diseases

Ghani, R., Mullish, B. H., Roberts, L. A., Davies, F., & Marchesi, J. R. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2038856 · Cited by 42 · see citing works

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

Mullish, B. H., Merrick, B., Quraishi, M. N., Bak, A., Green, C., Moore, D., Porter, R. J., Elumogo, N., Segal, J. P., Sharma, N., et al. (2024) · Journal of Hospital Infection · doi:10.1016/j.jhin.2024.03.001 · Cited by 41 · see citing works

Clostridioides difficile Infection: Diagnosis and Treatment Challenges

Markantonis, J., Fallon, J. T., Madan, R., & Alam, M. Z. (2024) · Pathogens · doi:10.3390/pathogens13020118 · Cited by 38 · see citing works

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

Mullish, B. H., Merrick, B., Quraishi, M. N., Bak, A., Green, C., Moore, D., Porter, R. J., Elumogo, N., Segal, J. P., Sharma, N., et al. (2024) · Gut · doi:10.1136/gutjnl-2023-331550 · Cited by 35 · see citing works

Fecal microbiota transplantation: application scenarios, efficacy prediction, and factors impacting donor-recipient interplay

Liu, Y., Li, X., Chen, Y., Yao, Q., Zhou, J., Wang, X., Meng, Q., Ji, J., Yu, Z., & Chen, X. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1556827 · Cited by 37 · see citing works

Fecal microbiota transplantation for recurrent Clostridioides difficile , safety, and pitfalls

Sandhu, A., & Chopra, T. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211053105 · Cited by 38 · see citing works

Fecal Microbiota Transplantation: Tales of Caution

Khanna, S., & Kraft, C. S. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1492 · Cited by 33 · see citing works

Integrating microbiome science and evolutionary medicine into animal health and conservation

Bornbusch, S. L., Power, M. L., Schulkin, J. A., Drea, C. M., Maslanka, M., & Muletz‐Wolz, C. R. (2023) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.13030 · Cited by 32 · see citing works

The Age of Next-Generation Therapeutic-Microbe Discovery: Exploiting Microbe-Microbe and Host-Microbe Interactions for Disease Prevention

Cruz, N., Abernathy, G. A., Dichosa, A. E. K., & Kumar, A. (2022) · Infection and Immunity · doi:10.1128/iai.00589-21 · Cited by 33 · see citing works

Gut microbiota in rheumatoid arthritis: Mechanistic insights, clinical biomarkers, and translational perspectives

Qi, X., Liu, M., Jiang, X., Gao, T., Xu, G., Zhang, H., Su, Q. Y., Du, Y., Luo, J., & Zhang, S. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103912 · Cited by 35 · see citing works

Microbiome-pathogen interactions drive epidemiological dynamics of antibiotic resistance: A modeling study applied to nosocomial pathogen control

Smith, D. R., Temime, L., & Opatowski, L. (2021) · eLife · doi:10.7554/elife.68764 · Cited by 30 · see citing works

Fecal Microbiota Transplantation Donor Screening Updates and Research Gaps for Solid Organ Transplant Recipients

Mehta, N., Wang, T. L., Friedman‐Moraco, R., Carpentieri, C., Mehta, A. K., Rouphael, N., Dhere, T., Larsen, C. P., Kraft, C. S., & Woodworth, M. H. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00161-21 · Cited by 32 · see citing works

Gut microbiome-based strategies for host health and disease

Wang, C., Bai, J., Chen, X., Song, J., Zhang, Y., Wang, H., & Suo, H. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2176464 · Cited by 29 · see citing works

Controversies in the Prevention and Treatment of Clostridioides difficile Infection in Adults: A Narrative Review

Bainum, T. B., Reveles, K. R., Hall, R. G., Cornell, K., & Álvarez, C. A. (2023) · Microorganisms · doi:10.3390/microorganisms11020387 · Cited by 29 · see citing works

Long-Term Safety Following Faecal Microbiota Transplantation as a Treatment for Recurrent Clostridioides difficile Infection Compared with Patients Treated with a Fixed Bacterial Mixture: Results from a Retrospective Cohort Study

Cold, F., Svensson, C. K., Petersen, A. M., Hansen, L. H., & Helms, M. (2022) · Cells · doi:10.3390/cells11030435 · Cited by 27 · see citing works

Clostridioides difficile pathogenesis and control

Chilton, C. H., Viprey, V. F., Normington, C., Moura, I. B., Buckley, A. M., Freeman, J., Davies, K., & Wilcox, M. H. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01242-2 · Cited by 26 · see citing works

End-to-end donor screening and manufacturing controls: complementary quality-based strategies to minimize patient risk for donor-derived microbiome therapeutics

Goldsmith, J. R., Tomkovich, S., Aunins, J. G., McGovern, B., Mahoney, J. C., Hasson, B. R., McChalicher, C. W. J., & Ege, D. S. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2402550 · Cited by 22 · see citing works

Effects of fecal microbiota transplantation and fecal virome transplantation on LPS-induced intestinal injury in broilers

Wu, D., Liang, S., Du, X., Xiao, J., Feng, H., Ren, Z., Yang, X., & Yang, X. (2023) · Poultry Science · doi:10.1016/j.psj.2023.103316 · Cited by 20 · see citing works

Microbiota restoration for recurrent Clostridioides difficile: Getting one step closer every day!

Khanna, S. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13290 · Cited by 18 · see citing works

Transmission of the Potential Pathogen Atypical Enteropathogenic Escherichia coli by Fecal Microbiota Transplant

Kralicek, S. E., Jenkins, C., Allegretti, J. R., Lewis, J. D., Osman, M., & Hecht, G. A. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.03.222 · Cited by 17 · see citing works

Safety of fecal microbiota transplantation for Clostridioides difficile infection focusing on pathobionts and SARS-CoV-2

Yadav, D., & Khanna, S. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211009694 · Cited by 17 · see citing works

High Dose Intramuscular Vitamin D3 Supplementation Impacts the Gut Microbiota of Patients With Clostridioides Difficile Infection

Lee, S. H., Park, H., Kang, C. D., Choi, D. H., Park, S. C., Park, J. M., Nam, S., Chae, G., Lee, K. Y., Cho, H., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.904987 · Cited by 17 · see citing works

High carriage rate of extended‐spectrum β‐lactamase Enterobacterales and diarrheagenic Escherichia coli in healthy donor screening for fecal microbiota transplantation

Chuang, C., Lee, K., Wang, Y., Lee, P., Chang, T.-E., Huang, Y., Lin, Y.-T., & Hou, M. (2023) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-023-04644-3 · Cited by 16 · see citing works

Can FMT Cause or Prevent CRC? Maybe, But There Is More to Consider

Khoruts, A. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.06.074 · Cited by 16 · see citing works

Advancements in Novel Live Biotherapeutic Products for Clostridioides difficile Infection Prevention

Lavoie, T., Appaneal, H. J., & LaPlante, K. L. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad639 · Cited by 15 · see citing works

The Efficacy of Faecal Microbiota Transplant and Rectal Bacteriotherapy in Patients with Recurrent Clostridioides difficile Infection: A Retrospective Cohort Study

Svensson, C. K., Cold, F., Ribberholt, I., Zangenberg, M., Mirsepasi‐Lauridsen, H. C., Petersen, A. M., & Helms, M. (2022) · Cells · doi:10.3390/cells11203272 · Cited by 16 · see citing works

What is unknown in using microbiota as a therapeutic?

Sung, J. J. �., & Wong, S. H. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15716 · Cited by 14 · see citing works

Transmission of Antibiotic-Susceptible Escherichia coli Causing Urinary Tract Infections in a Fecal Microbiota Transplantation Recipient: Consequences for Donor Screening?

Vendrik, K. E. W., de Meij, T. G. J., Bökenkamp, A., Ooijevaar, R. E., Groenewegen, B., Hendrickx, A. P. A., Terveer, E. M., Kuijper, E. J., & van Prehn, J. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac324 · Cited by 14 · see citing works

Interaction mechanism and intervention strategy between metabolic dysfunction-associated steatotic liver disease and intestinal microbiota

Yang, W., Jin, Q., Xiao, D., Li, X., & Huang, D. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1597995 · Cited by 13 · see citing works

The future of clinical trials of gut microbiome therapeutics in cirrhosis

Bloom, P. P., & Chung, R. T. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101234 · Cited by 14 · see citing works

Non-pharmaceutical treatments for irritable bowel syndrome

Wang, X., Thakur, E. R., & Shapiro, J. M. (2024) · BMJ · doi:10.1136/bmj-2023-075777 · Cited by 13 · see citing works

Fecal microbiota transplantation holds the secret to youth

Meng, Y., Sun, J., & Zhang, G. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111823 · Cited by 13 · see citing works

Microbiome therapeutics for the treatment of recurrent Clostridioides difficile infection

Bloom, P. P., & Young, V. B. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2154600 · Cited by 12 · see citing works

Alteration of gut microbial composition associated with the therapeutic efficacy of fecal microbiota transplantation in Clostridium difficile infection

Lee, P., Chang, T.-E., Wang, Y., Lee, K., Lin, Y.-T., Chiou, J.-J., Huang, C.-W., Yang, U., Li, F.-Y., Huang, H., et al. (2021) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2021.11.001 · Cited by 12 · see citing works

Beyond faecal microbiota transplantation, the non-negligible role of faecal virome or bacteriophage transplantation

Wu, D., Zhang, C., Liu, Y., Yao, J., Yang, X., Wu, S., Du, J., & Yang, X. (2023) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2023.02.005 · Cited by 12 · see citing works

Identification of novel p-cresol inhibitors that reduce Clostridioides difficile’s ability to compete with species of the gut microbiome

Harrison, M. A., Farthing, R. J., Allen, N., Ahern, L. M., Birchall, K., Bond, M., Kaur, H., Wren, B. W., Bergeron, J. R. C., & Dawson, L. F. (2023) · Scientific Reports · doi:10.1038/s41598-023-32656-8 · Cited by 11 · see citing works

Host Immune Responses to Clostridioides difficile Infection and Potential Novel Therapeutic Approaches

Alam, M. Z., Markantonis, J., & Fallon, J. T. (2023) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed8120506 · Cited by 10 · see citing works

Fecal Microbiome Transplantation for Recurrent Clostridioides difficile Infection: Treatment Efficacy, Short and Long-term Follow-up Results from Consecutive Case Series

Urbonas, T., Ianiro, G., Gedgaudas, R., Šabanas, P., Urba, M., Kiudelis, V., Kiudelis, G., Petkevičius, V., Vitkauskienė, A., Cammarota, G., et al. (2021) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-3800 · Cited by 10 · see citing works

Towards optimising and standardising donor screening for faecal microbiota transplantion

Liu, C. S., Merrick, B., Taboun, Z. S., Mullish, B. H., Goldenberg, S. D., Terveer, E. M., Porcari, S., Bradbury, R. S., Ianiro, G., Ng, S. C., et al. (2025) · Gut · doi:10.1136/gutjnl-2025-336532 · Cited by 13 · see citing works

Therapeutic interventions and mechanisms associated with gut microbiota-mediated modulation of immune checkpoint inhibitor responses

Wong, M., Barbulescu, P., Coburn, B. A., & Reguera-Nuñez, E. (2021) · Microbes and Infection · doi:10.1016/j.micinf.2021.104804 · Cited by 9 · see citing works

Fecal microbiota transplants facilitate post-antibiotic recovery of gut microbiota in cheetahs (Acinonyx jubatus)

Bornbusch, S. L., Crosier, A. E., Gentry, L. K., Delaski, K. M., Maslanka, M., & Muletz‐Wolz, C. R. (2024) · Communications Biology · doi:10.1038/s42003-024-07361-5 · Cited by 8 · see citing works

Manufacturing Processes of a Purified Microbiome Therapeutic Reduce Risk of Transmission of Potential Bacterial Pathogens in Donor Stool

McChalicher, C. W. J., Lombardo, M., Khanna, S., McKenzie, G. J., Halvorsen, E. M., Almomani, S., Schuster, B., Hasson, B. R., McGovern, B., Ege, D. S., et al. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad298 · Cited by 8 · see citing works

Encapsulation protocol for fecal microbiota transplantation

Sipos, D., Varga, A., Kappéter, Á., Halda-Kiss, B., Kása, P., Pál, S., Kocsis, B., & Péterfi, Z. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1424376 · Cited by 8 · see citing works

Is Autologous Fecal Microbiota Transfer after Exclusive Enteral Nutrition in Pediatric Crohn’s Disease Patients Rational and Feasible? Data from a Feasibility Test

Hoelz, H., Heetmeyer, J., Tsakmaklis, A., Hiergeist, A., Siebert, K., Zen, F. D., Häcker, D., Metwaly, A., Neuhaus, K., Gessner, A., et al. (2023) · Nutrients · doi:10.3390/nu15071742 · Cited by 6 · see citing works

Escape Velocity—the Launch of Microbiome Therapies

Kelly, B. J., Kwon, J. H., & Woodworth, M. H. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae099 · Cited by 6 · see citing works

Microbiome-Related and Infection Control Approaches to Primary and Secondary Prevention of Clostridioides difficile Infections

McFarland, L. V., Goldstein, E. J. C., & Kullar, R. (2023) · Microorganisms · doi:10.3390/microorganisms11061534 · Cited by 6 · see citing works

The Gut–Brain–Immune Axis in Glioma: Emerging Mechanisms and Therapeutic Opportunities

Feng, R., Yang, Z., Zhou, Y., & Zhao, H. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01680-3 · Cited by 7 · see citing works

15-strain live biotherapeutic product or same donor fecal microbiota transplant for recurrent Clostridioides difficile infection: a randomized phase 1b trial

Bethlehem, L., Bartu, L., Marke, G., Mar, P., Feldman, S., Eggers, J., Ruprecht, C., Britton, G. J., Aggarwala, V., Bongers, G., et al. (2026) · Nature Medicine · doi:10.1038/s41591-026-04442-2 · Cited by 6 · see citing works

Recurrent Clostridioides difficile Infection and Outcome of Fecal Microbiota Transplantation Use: A Population-Based Assessment

Mehta, N., Goodenough, D., Gupta, N., Thomas, S., Mehta, C. C., Prakash, R., Woodworth, M. H., Kraft, C. S., & Fridkin, S. K. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae309 · Cited by 5 · see citing works

A model screening pipeline for bile acid converting anti- Clostridioides difficile bacteria reveals unique biotherapeutic potential of Peptacetobacter hiranonisPreprint

Vinithakumari, A. A., Hernandez, B. G., Ghimire, S., Adams, S., Stokes, C., Jepsen, I., Brezina, C., Şahin, O., Li, G., Tangudu, C. S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.29.462466 · Cited by 5 · see citing works

Profiling the gut resistome to unlock antimicrobial resistance biology and inform clinical risk

Chaudhry, Z., Cazares, A., Thomson, N. R., & Heyderman, R. S. (2026) · Nature Communications · doi:10.1038/s41467-026-75659-5 · Cited by 5 · see citing works

Treatment and Management of Gastrointestinal Disorders

Montgomery, G., Patel, A., & Pfeil, S. A. (2024) · Medical Clinics of North America · doi:10.1016/j.mcna.2024.03.010 · Cited by 4 · see citing works

Roles of the gut microbiota in cancer immunotherapy: Mechanistic foundations and therapeutic opportunities

Wu, Q., Zhou, Y.-R., Chen, Z.-R., Liu, M.-X., Liu, M.-X., Liu, Y.-F., Li, Z., Zhao, Q.-R., Zhang, Y.-Q., Zhang, H., et al. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105230 · Cited by 4 · see citing works

Advances and challenges in microbiome transplantation

Sen, P., Kaulmann, D., Youngster, I., Abdeen, S. K., & Elinav, E. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.06.006 · Cited by 4 · see citing works

Future Microbiome Therapeutics for Clostridioides difficile Infection

Fischer, M., & Ray, A. (2023) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002576 · Cited by 3 · see citing works

Assessing healthcare workers as potential stool donors for faecal microbiota transplantation: a cross-sectional study of antimicrobial-resistant gut bacteria and enteropathogenic micro-organisms

Moreno, M. B., Medina-Gómez, C., Núñez, D. G., Saiz-Escobedo, L., Martí, S., Domínguez, M. Á., Carrera-Salinas, A., & Rodríguez-Sevilla, G. (2025) · Journal of Hospital Infection · doi:10.1016/j.jhin.2025.09.004 · Cited by 2 · see citing works

The Expanding Landscape of Microbiota Medicine: Indications, Therapeutic Modalities, and the Path Towards Integrative Microbiome‐Targeting Healthcare

Dai, M., Lin, Y., Gan, R., Shen, X., Park, S. Y., Lee, S., & Su, Q. (2026) · Microbiota Medicine Research · doi:10.1002/mmr3.70004 · Cited by 2 · see citing works

Trasplante de microbiota fecal como alternativa de tratamiento por infecciones de clostridoides difficile

Narváez, N. S. F., & Jerves, J. A. T. (2023) · Revista Vive · doi:10.33996/revistavive.v6i16.207 · Cited by 3 · see citing works

An optimal normalization method for high sparse compositional microbiome data

Sohn, M. B., Monaco, C. L., & Gill, S. R. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012338 · Cited by 2 · see citing works

Double-edged sword: impact of fecal microbiome transplants on the gut resistome

Hallowell, H. A., Gao, A. L., & Suez, J. (2022) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000894 · Cited by 2 · see citing works

Microbial Therapeutics in Liver Disease

Bajaj, J. S., & Khoruts, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00193-6 · Cited by 2 · see citing works

Live biotherapeutic product exhibits similar efficacy and superior engraftment to same donor fecal microbiota transplant for recurrent Clostridioides difficile infectionPreprint

Bethlehem, L., Bartu, L., Marke, G., Mar, P., Feldman, S., Eggers, J., Ruprecht, C., Britton, G. J., Aggarwala, V., Bongers, G., et al. (2025) · medRxiv · doi:10.1101/2025.09.08.25335342 · Cited by 2 · see citing works

Faecal transplantation: the good, the bad and the ugly

Sin, H. C. L., & Haifer, C. (2024) · Internal Medicine Journal · doi:10.1111/imj.16559 · Cited by 1 · see citing works

The gut microbiome and colorectal cancer

Dietz, M. A., Subramanian, S., & Staley, C. M. (2026) · Clinical Microbiology Reviews · doi:10.1128/cmr.00332-25 · Cited by 1 · see citing works

Outcomes of Fecal Microbiota Transplantation for Clostridioides difficile Infection in South Australia

Tucker, E. C., Angelica, B., Mathias, R. M., Edwards, L., Bryant, R. V., & Costello, S. P. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf149 · Cited by 2 · see citing works

Pathophysiological Prerequisites and Therapeutic Potential of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis

Garbuzenko, D. V. (2022) · The Russian Archives of Internal Medicine · doi:10.20514/2226-6704-2022-12-5-352-362

Additional file 1 of Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial

Orenstein, R., Dubberke, E. R., Khanna, S., Lee, C., Yoho, D., Johnson, S., Hecht, G. A., Dupont, H. L., Gerding, D. N., Blount, K. F., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19351485

Mathematical modelling and simulation of the transmission, surveillance and control of human pathogens in healthcare settings

Smith, D. R. (2021) · doi:10.70675/40b80716z75edz495ezaa7fz39000eea8928

Rôles des polysaccharides de surface de Clostridioides difficile dans la physiopathologie : cibles thérapeutiques et vaccinales ?

Malet-Villemagne, J. (2022) · doi:10.70675/dcdc2ad0z8b91z4774z97a2zad2f42b36f14

Ancient Ayurveda Meets Modern Science: The Role of Panchakarma in Modulating Gut-Organ Axes - A Narrative Review

Bhatia, B., Shamkuwar, M., & ., M. (2026) · Journal of Natural Remedies · doi:10.18311/jnr/2026/45718

Fecal Microbiota Transplantation as a Therapeutic Adjuvant in Gastrointestinal Cancers: Potential Mechanisms, Therapeutic Applications, and a Functional Donor Screening Strategy

Wang, Y., Li, Z., & Kong, X. (2026) · Cancer Screening and Prevention · doi:10.14218/csp.2026.00033

Exercise-driven microbiome changes regulate host immunity

Phelps, C. M., & Meisel, M. (2026) · Trends in Immunology · doi:10.1016/j.it.2026.08.001 · Cited by 1 · see citing works

Intestinal Microbiota Structure of Xichuan Black-Bone Chickens and Preliminary Evaluation of a Probiotic-Based Fecal Microbiota Substitute

Yuan, L., Zhang, C., Li, W., Yi, J., Liu, C., Jin, W., Li, G., Wang, B., Li, S., & Wang, H. (2026) · Microorganisms · doi:10.3390/microorganisms14091966

Deciphering the gut-lung axis in non-small cell lung cancer: from immune microenvironment crosstalk to clinical translation

Sun, C., Han, F., Xu, W., Wang, X., & Wang, X. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1975256

From maternal microbial transmission to neonatal gut microbiota restoration: the potential and challenges of maternal fecal microbiota transplantation

Hu, X., Ma, G., Han, J., 朱丽娟, He, Y., & Zhu, D. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1972665

Transmission of the Potential Pathogen Atypical Enteropathogenic Escherichia coli by Fecal Microbiota Transplant

Kralicek, S. E., Jenkins, C., Allegretti, J. R., Lewis, J. D., Osman, M., & Hecht, G. A. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.03.222 · Cited by 17 · see citing works

Faecal microbiota transplantation: more screening for old and new pathogens

Hohmann, E. L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30850-1 · Cited by 6 · see citing works

Transmission and clearance of potential procarcinogenic bacteria during fecal microbiota transplantation for recurrent Clostridioides difficile

Drewes, J. L., Corona, A., Sanchez, U., Fan, Y., Hourigan, S. K., Weidner, M., Sidhu, S. D., Simner, P. J., Wang, H., Timp, W., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.130848 · Cited by 64 · see citing works

Enterotoxigenic Clostridium perfringens Infection as an Adverse Event After Faecal Microbiota Transplantation in Two Patients With Ulcerative Colitis and Recurrent Clostridium difficile Infection: A Neglected Agent in Donor Screening

Azimirad, M., Yadegar, A., Aghdaei, H. A., & Kelly, C. R. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz006 · Cited by 28 · see citing works

Safety of fecal microbiota transplantation for Clostridioides difficile infection focusing on pathobionts and SARS-CoV-2

Yadav, D., & Khanna, S. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211009694 · Cited by 17 · see citing works